摘要
新药研发是医药创新发展的关键环节,是新一轮生命科技革命和生物经济变革的核心领域,对引领科技创新、带动经济发展、提升人民健康福祉具有战略意义.当前,前沿技术不断革新、学科跨域融合、数字深度赋能驱动新药研发领域创新日趋活跃,国内外创新性小分子药物、抗体药物、免疫细胞治疗、基因治疗与核酸药物等密集获批上市,为未满足的临床需求提供更多选择.文章深入分析新药研发领域发展趋势、全球新药批准情况,以及我国新药研发发展现状与态势,提出发展启示与建议,以期为新药研发领域发展提供参考.
Abstract
As an important component in the pharmaceutical innovation,research and development(R&D)of new drugs stands at the forefront of a new round of life science and technology revolution and bioeconomic reform,which is of strategic significance to leading scientific and technological innovation,driving economic development,and improving people's health and well-being.At present,continuous innovation in cutting-edge technologies,cross-domain integration of disciplines,and digital depth enablement drive active innovation in the field of new drug R&D.Both domestically and internationally,innovative small molecule drugs,antibody drugs,immune cell therapy,gene therapy and nucleic acid drugs are receiving intensive market approvals,providing a wider range of solutions for unmet clinical needs.This study analyzes the development trend of new drug R&D,the global approval situation of new drug R&D,as well as the current situation and trend of new drug R&D in China.It puts forward development enlightenment and suggestions,in order to provide reference for the development of new drug research and development.
基金项目
中国科学院科技智库研究员项目(2023-ZY06-B-032)
NETL
NSTL
万方数据